Edmonton, Canada

David S Tam

This inventor holds 1 USPTO granted patent, plus 2 CIPO patents. Top assignee: Nou Life Sciences, Inc.. Active years: 2012.


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: David S. Tam: Innovator in Carnitine Compounds

Introduction

David S. Tam is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of biochemistry, particularly through his innovative work on carnitine compounds. His research focuses on developing novel compounds that can aid in preventing or treating diseases associated with free radicals.

Latest Patents

David S. Tam holds a patent for a cleavable carnitine compound. This invention includes novel compounds, including but not limited to formula A and formula B, along with an improved delivery method. These compounds and methods are useful in preventing or treating diseases or conditions caused by the presence of free radicals. They also play a role in increasing cellular metabolism while alleviating the resultant increase in oxidative stress. Specifically, a carnitine is bound to a lipoic acid derivative or to dihydrolipoic acid or its derivatives using a hydrolysable linker to form a single compound. He has 1 patent to his name.

Career Highlights

David S. Tam is currently associated with Nou Life Sciences, Inc., where he continues to advance his research and development efforts. His work is pivotal in the field of health sciences, particularly in the context of metabolic disorders.

Collaborations

He collaborates with notable professionals in his field, including Antoine Noujiam and Bruce D. Hirsche, who serves as the legal representative for his patent endeavors.

Conclusion

David S. Tam's innovative work on cleavable carnitine compounds showcases his commitment to advancing health sciences. His contributions are significant in the ongoing battle against diseases linked to oxidative stress and free radicals.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…